Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['lenalidomide', 'cilta-cel', ' lena', 'multiple myeloma', 'cartitude', 'cartitude-4']
original article: cilta-cel or standard care in lenalidomide-refractory multiple myeloma (cartitude-4) #asco23
The New England Journal of Medicine (https://t.co/YGfDrRsIhE) is the world’s leading medical journal and website.